Kairos Pharma | 8-K: Current report

Feb 26 07:07 ET

Kairos Pharma | DEF 14C: Definitive information statements

Feb 10 16:46 ET

Kairos Pharma | 8-K: Current report

Feb 6 09:05 ET

Kairos Pharma | S-1: General form for registration of securities under the Securities Act of 1933

Jan 29 06:40 ET

Kairos Pharma | 8-K: Current report

Jan 17 17:24 ET

Kairos Pharma | 8-K: Current report

Jan 14 09:42 ET

Kairos Pharma | 8-K: Current report

Dec 13, 2024 16:11 ET

Kairos Pharma | 8-K: Current report

Nov 19, 2024 08:51 ET

Kairos Pharma | 8-K: Current report

Oct 10, 2024 17:35 ET

Kairos Pharma | 8-K: Current report

Oct 4, 2024 17:34 ET

Kairos Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Sep 27, 2024 17:19 ET

Kairos Pharma | 8-K: Current report

Sep 27, 2024 17:14 ET

Kairos Pharma | 8-K: Current report

Sep 24, 2024 16:27 ET

Kairos Pharma | 8-K: Current report

Sep 17, 2024 16:20 ET

Kairos Pharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Aug 16, 2024 17:34 ET

Kairos Pharma, Ltd. | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jun 4, 2024 22:21 ET

Kairos Pharma, Ltd. | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 24, 2024 05:02 ET

Kairos Pharma, Ltd. | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 20, 2024 05:02 ET

Kairos Pharma, Ltd. | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 13, 2024 05:02 ET

Kairos Pharma, Ltd. | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 1, 2024 05:02 ET